. | Health status . | ||
---|---|---|---|
. | Healthy . | Complex/intermediate . | Very complex/poor . |
n | 582 | 766 | 493 |
Visit 5 age (years), mean (SD) | 73.5 (4.2) | 75.5 (4.9) | 77.5 (5.5) |
Women | 305 (52.4) | 411 (53.7) | 312 (63.3) |
Black | 159 (27.3) | 178 (23.2) | 188 (38.1) |
Number of medications,* mean (SD) | 9.3 (4.7) | 10.9 (4.9) | 11.4 (5.0) |
A1C | |||
<7% | 433 (74.4) | 547 (71.4) | 337 (68.4) |
7 to <8% | 101 (17.4) | 143 (18.7) | 90 (18.3) |
≥8% | 48 (8.2) | 76 (9.9) | 66 (13.4) |
Diabetes medication | |||
None | 257 (44.2) | 289 (37.7) | 166 (33.7) |
Noninsulin/sulfonylurea only | 159 (27.3) | 192 (25.1) | 115 (23.3) |
Insulin or sulfonylurea | 166 (28.5) | 285 (37.2) | 212 (43.0) |
Diabetes duration ≥10 years | 196 (33.7) | 341 (44.5) | 284 (57.6) |
Comorbidities | |||
Arthritis | 238 (40.9) | 618 (80.7) | 414 (84.0) |
Cancer | 54 (9.3) | 258 (33.7) | 122 (24.7) |
CKD† | 124 (21.3) | 534 (69.7) | 354 (71.8) |
Coronary heart disease | 25 (4.3) | 219 (28.6) | 105 (21.3) |
Depression | 14 (2.4) | 94 (12.3) | 68 (13.8) |
Emphysema or COPD | 8 (1.4) | 91 (11.9) | 48 (9.7) |
Heart failure | 9 (1.5) | 192 (25.1) | 151 (30.6) |
History of hospitalized fall | 5 (0.9) | 34 (4.4) | 34 (6.9) |
History of severe hypoglycemia | 3 (0.5) | 22 (2.9) | 32 (6.5) |
Hypertension | 418 (71.8) | 707 (92.3) | 426 (86.4) |
Incontinence | 14 (2.4) | 133 (17.4) | 104 (21.1) |
Stroke | 9 (1.5) | 40 (5.2) | 49 (9.9) |
Dementia‡ | — | — | 86 (17.4) |
Frailty | — | — | 191 (38.7) |
Poor physical function | — | — | 382 (77.5) |
. | Health status . | ||
---|---|---|---|
. | Healthy . | Complex/intermediate . | Very complex/poor . |
n | 582 | 766 | 493 |
Visit 5 age (years), mean (SD) | 73.5 (4.2) | 75.5 (4.9) | 77.5 (5.5) |
Women | 305 (52.4) | 411 (53.7) | 312 (63.3) |
Black | 159 (27.3) | 178 (23.2) | 188 (38.1) |
Number of medications,* mean (SD) | 9.3 (4.7) | 10.9 (4.9) | 11.4 (5.0) |
A1C | |||
<7% | 433 (74.4) | 547 (71.4) | 337 (68.4) |
7 to <8% | 101 (17.4) | 143 (18.7) | 90 (18.3) |
≥8% | 48 (8.2) | 76 (9.9) | 66 (13.4) |
Diabetes medication | |||
None | 257 (44.2) | 289 (37.7) | 166 (33.7) |
Noninsulin/sulfonylurea only | 159 (27.3) | 192 (25.1) | 115 (23.3) |
Insulin or sulfonylurea | 166 (28.5) | 285 (37.2) | 212 (43.0) |
Diabetes duration ≥10 years | 196 (33.7) | 341 (44.5) | 284 (57.6) |
Comorbidities | |||
Arthritis | 238 (40.9) | 618 (80.7) | 414 (84.0) |
Cancer | 54 (9.3) | 258 (33.7) | 122 (24.7) |
CKD† | 124 (21.3) | 534 (69.7) | 354 (71.8) |
Coronary heart disease | 25 (4.3) | 219 (28.6) | 105 (21.3) |
Depression | 14 (2.4) | 94 (12.3) | 68 (13.8) |
Emphysema or COPD | 8 (1.4) | 91 (11.9) | 48 (9.7) |
Heart failure | 9 (1.5) | 192 (25.1) | 151 (30.6) |
History of hospitalized fall | 5 (0.9) | 34 (4.4) | 34 (6.9) |
History of severe hypoglycemia | 3 (0.5) | 22 (2.9) | 32 (6.5) |
Hypertension | 418 (71.8) | 707 (92.3) | 426 (86.4) |
Incontinence | 14 (2.4) | 133 (17.4) | 104 (21.1) |
Stroke | 9 (1.5) | 40 (5.2) | 49 (9.9) |
Dementia‡ | — | — | 86 (17.4) |
Frailty | — | — | 191 (38.7) |
Poor physical function | — | — | 382 (77.5) |
Data are n (%) unless otherwise indicated.
Inclusive of prescription and over-the-counter medications and dietary supplements.
CKD refers to stage 3+ (estimated glomerular filtration rate <60 mL/min/1.73 m2) or albuminuria (albumin-to-creatinine ratio ≥30 mg/g).
By definition, “—” means that there are no participants in this category (i.e., dementia, frailty, or poor physical function were used to define the very complex/poor heath category).